Study details
Enrolling now
GRID Therapy for Extremity Soft Tissue Sarcoma
UNC Lineberger Comprehensive Cancer Center
NCT IDNCT06073067ClinicalTrials.gov data as of Apr 2026
Target enrollment
20
Study length
about 2.8 years
Ages
18+
Locations
1 site in NC
What this study is about
This trial is testing GRID therapy, a technique that may increase radiation dose with minimal added toxicity, to improve tumor response in patients with high-risk extremity soft tissue sarcoma. The goal of this single-arm pilot trial is to assess the safety and clinical efficacy of GRID radiation therapy on 20 subjects before standard radiotherapy and tumor resection.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive GRID therapy
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.